
MD
Pediatrix Medical Group Inc.
Company Overview
| Mkt Cap | $1.96B | Price | $21.74 |
| Volume | 674.56K | Change | +0.00% |
| P/E Ratio | -19.8 | Open | $21.81 |
| Revenue | $2.0B | Prev Close | $21.74 |
| Net Income | $-99.1M | 52W Range | $11.84 - $24.99 |
| Div Yield | N/A | Target | $21.33 |
| Overall | 66 | Value | 80 |
| Quality | 47 | Technical | 72 |
No chart data available
About Pediatrix Medical Group Inc.
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal medicine nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and other newborn and pediatric care, as well as newborn hearing screening, and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
Latest News
‘Forget Nvidia,’ Says Top Investor as AMD Stock’s AI Moment Is Near
Alstom Wins €295 Million European Signalling Contract
Why Is Micron Stock Rallying 11% in Pre-Market Trading, 4/8/26?
Mizuho Securities Remains a Buy on Relmada Therapeutics (RLMD)
ResMed CEO Michael Farrell Plans Additional Insider Sale Under Rule 144
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MD | $21.74 | 0% | 674.56K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Pediatrix Medical Group Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW